About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Bevacizumab and Vasoconstriction

NCT00929058·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Radboud University Medical Center

Age

18–50

Sex

MALE

Healthy volunteers

Accepted

You may be eligible if

Male 18-50 years old
normal results of glucose, lipids and creatinine
informed consent

You may not be if

History of abuse of drugs or alcohol
History of malignant disease
First degree relatives with a history of cancer before the age of 50
First degree relatives with a history of premature cardiovascular disease
Current use of medication
Clinical evidence of cardiac of pulmonary disease
Hypertension ( systolic\>140mmHg, diastolic \>90mmHg)
Diabetes mellitus
smoking
a history of thombosis or a family history of recurrent thrombosis
abnormality on ECG

The record

StatusCompleted

PhaseNo phase

Taking part10

StartedJun 2009

UpdatedMay 18, 2010

Conditions

Hypertension Cancer

Where1

Radboud University Nijmegen Medical Centre
Nijmegen, Netherlands

Clareo Health | Bevacizumab and Vasoconstriction